Ghe LLC boosted its position in Colgate-Palmolive (NYSE:CL – Free Report) by 1.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 21,288 shares of the company’s stock after buying an additional 350 shares during the quarter. Colgate-Palmolive makes up about 0.8% of Ghe LLC’s holdings, making the stock its 27th largest position. Ghe LLC’s holdings in Colgate-Palmolive were worth $1,935,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of CL. Swedbank AB increased its position in Colgate-Palmolive by 1.4% in the third quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after buying an additional 40,324 shares during the last quarter. International Assets Investment Management LLC grew its position in shares of Colgate-Palmolive by 13,776.8% in the third quarter. International Assets Investment Management LLC now owns 435,871 shares of the company’s stock valued at $45,248,000 after purchasing an additional 432,730 shares in the last quarter. Allworth Financial LP grew its position in shares of Colgate-Palmolive by 16.2% in the third quarter. Allworth Financial LP now owns 17,890 shares of the company’s stock valued at $1,857,000 after purchasing an additional 2,500 shares in the last quarter. NorthCrest Asset Manangement LLC purchased a new position in shares of Colgate-Palmolive in the third quarter valued at $208,000. Finally, Wealth Enhancement Advisory Services LLC grew its position in shares of Colgate-Palmolive by 16.4% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 254,923 shares of the company’s stock valued at $26,464,000 after purchasing an additional 35,986 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on CL. TD Cowen reduced their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. UBS Group reduced their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Morgan Stanley reduced their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Finally, Barclays reduced their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $101.16.
Colgate-Palmolive Stock Up 1.9 %
NYSE:CL opened at $89.56 on Monday. The firm has a market capitalization of $72.68 billion, a P/E ratio of 25.44, a PEG ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 1-year low of $84.45 and a 1-year high of $109.30. The company’s fifty day moving average price is $88.94 and its 200-day moving average price is $95.82. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the business earned $0.87 EPS. As a group, equities research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.23%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- Following Congress Stock Trades
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Basic Materials Stocks Investing
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- 3 Stocks to Consider Buying in October
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.